APA (7th ed.) Citation

Ramia de Cap, M., Wu, L. P., Hirt, C., Pihan, G. A., Patel, S. S., Tam, W., . . . Bagg, A. (2023). Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: A study from the Bone Marrow Pathology Group. Leukemia & Lymphoma, 64(5), 972. https://doi.org/10.1080/10428194.2023.2185091

Chicago Style (17th ed.) Citation

Ramia de Cap, Maximiliano, et al. "Myeloid Sarcoma with NPM1 Mutation May Be Clinically and Genetically Distinct from AML with NPM1 Mutation: A Study from the Bone Marrow Pathology Group." Leukemia & Lymphoma 64, no. 5 (2023): 972. https://doi.org/10.1080/10428194.2023.2185091.

MLA (9th ed.) Citation

Ramia de Cap, Maximiliano, et al. "Myeloid Sarcoma with NPM1 Mutation May Be Clinically and Genetically Distinct from AML with NPM1 Mutation: A Study from the Bone Marrow Pathology Group." Leukemia & Lymphoma, vol. 64, no. 5, 2023, p. 972, https://doi.org/10.1080/10428194.2023.2185091.